01 三月 2012

Riemser invests in Anwerina

RIEMSER Arzneimittel AG invests in anwerina AG, a life science company specialized in the development and marketing of innovative orthopedic pharmaceutical and medical products. VISCHER advises anwerina AG in the transaction. The team is led by partner Benedict F. Christ.

分享文章至:

包含的服务:

与我们的作者取得联系,受益于他们的专业知识:

partner-Benedict F.-0

Benedict F. Christ

benedict.christ@vischer.com

+41 58 211 34 62

我们的
新闻通讯